METAFORA BIOSYSTEMS has a total of 15 patent applications. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are TOKYO METROPOLITAN GERIATRIC HOSPITAL AND INST OF GERONTOLOGY, THERYTE LTD and MATSUMORI AKIRA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | China | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Petit Vincent | 15 |
#2 | Giovannini Donatella | 11 |
#3 | Battini Jean-Luc | 11 |
#4 | Sitbon Marc | 11 |
#5 | E Guangqi | 8 |
#6 | Lezaar Jawida | 6 |
#7 | Ivanova Svilena | 6 |
#8 | Touhami Jawida | 6 |
#9 | Sevestre Samuel | 5 |
#10 | Robert Bruno | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020070330A1 | Use of ligands derived from receptor-binding domain of porcine endogenous retrovirus type b for diagnosing smvt-related diseases | |
US2018335435A1 | Use of receptor-binding domain derived from bovine leukemia virus for the diagnosis or treatment of cationic l-amino acid transporter-related diseases | |
WO2017060304A1 | Receptor-binding domains ligands for the detection, diagnosis and treatment of pancreatic cancer | |
WO2016001431A1 | In vitro assays for assessing cell aging |